Cargando…
Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
Tumor tissues from biopsies or surgery are major sources for the next generation sequencing (NGS) study, but these procedures are invasive and have limitation to overcome intratumor heterogeneity. Recent studies have shown that driver alterations in tumor tissues can be detected by liquid biopsy whi...
Autores principales: | Lee, Jieun, Cho, Sung-Min, Kim, Min Sung, Lee, Sug Hyung, Chung, Yeun-Jun, Jung, Seung-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389948/ https://www.ncbi.nlm.nih.gov/pubmed/28416949 http://dx.doi.org/10.5808/GI.2017.15.1.48 |
Ejemplares similares
-
Detection of KRAS mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers
por: Min, Suji, et al.
Publicado: (2019) -
Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva
por: Han, Mi-Ryung, et al.
Publicado: (2018) -
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
por: Han, Mi-Ryung, et al.
Publicado: (2020) -
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
por: Chin, Yoon Ming, et al.
Publicado: (2020) -
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)